IP association: lack of data protection hinders drug development
Weak data protection rules in eight major economies are hurting US drug development companies, according to a major trade association of intellectual property owners.
To read more
Subscribe to Global Data Review
Subscribe and start reading now
The one-stop information source and community touchpoint, with coverage from across the areas of
- Data protection